Loading stock data…
LFST
$7.91-0.20 (-2.41%)
Market OpenUpdated 10:52 AM EDT
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
LifeStance Health Group, Inc. in the Healthcare sector is trading at $8.10. Wall Street consensus targets $10.61 (9 analysts), implying a +31.0% move over the next 12 months. The stock is currently near its 52-week high of $8.89, remaining 29.4% above its 200-day moving average. On fundamentals, Piotroski 8/9 indicates strong financial quality. The Whystock Score of 85/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +31.0% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Sector + growth-aware fair-multiple estimate. Fair P/E = sector-anchor + (ROE × 25) + (max(revenue growth, earnings growth) × 30), capped at 1.6× sector. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. The sector anchor (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) keeps quality compounders from being mechanically penalized against utility multiples. Result is a normalised multiple gauge — not a price target.
Current Price$7.91
Potential Downside
94.6%
Whystock Fair Value$0.43
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a multidisciplinary suite of mental health services...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$2.65B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
345.50
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.13
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-1.06%
Volume
Today's trading volume
903,294
Recent News
Earnings Estimates Rising for LifeStance Health (LFST): Will It Gain?
LifeStance Health Group (LFST) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
LifeStance Health Group (LFST) is a Great Momentum Stock: Should You Buy?
Does LifeStance Health Group (LFST) have what it takes to be a top stock pick for momentum investors? Let's find out.
Wall Street Analysts See a 31.02% Upside in LifeStance Health (LFST): Can the Stock Really Move This High?
The consensus price target hints at a 31% upside potential for LifeStance Health (LFST). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
LifeStance Health Group (LFST) Stock Trades Down, Here Is Why
Shares of behavioral health company LifeStance Health (NASDAQ:LFST) fell 11.7% in the afternoon session after the company announced the pricing of a large secondary offering by existing shareholders, reversing the prior day's rally.
LFST Q1 Deep Dive: Technology and Clinician Productivity Drive Outperformance and Guidance Increase
Behavioral health company LifeStance Health (NASDAQ:LFST) reported Q1 CY2026 results exceeding the market’s revenue expectations, with sales up 21.2% year on year to $403.5 million. On top of that, next quarter’s revenue guidance ($415 million at the midpoint) was surprisingly good and 3.9% above what analysts were expecting. Its non-GAAP profit of $0.07 per share was in line with analysts’ consensus estimates.